The Latest
Filter by Topic
Filter by Type
Cannabinoid-based medicine Epidiolex approved for sale in Canada
Canada's federal health regulator has approved Jazz Pharmaceuticals Canada's cannabinoid-based medicine Epidiolex as an adjunctive therapy for certain…
News November 30Cannabis stakeholders upbeat about prospects for end of 280E, stress need for risk-taking
Industry stakeholders speaking at MJBizCon on Wednesday expressed optimism that the Biden administration will reschedule marijuana as a…
News November 29Pricey Virginia medical marijuana driving patients to illicit market, study shows
Sticker shock at medical marijuana dispensaries in Virginia is spurring patients in the state to seek cheaper alternatives,…
News November 29Cannabis MSO Jushi files CA$600 million shelf prospectus
Cannabis multistate operator Jushi Holdings filed a preliminary short-form base shelf prospectus in Canada to raise up to…
News November 2922nd Century Group selling hemp operations for $2.25 million
Biotech company 22nd Century Group is selling off its hemp operations in a deal worth $2.25 million as…
News November 29MJBizCon 2023 opens with hopes for a brighter cannabis industry future
MJBizCon, the world's biggest event in the cannabis sector, kicks off Wednesday in Las Vegas as industry leaders…
News November 29New Hampshire governor interrupts adult-use marijuana legalization plan
Last-minute tinkering from New Hampshire’s Republican governor has disrupted lawmakers’ plans to legalize adult-use marijuana in the state.
News November 28Sahani replacing Dumas de Rauly as CEO of Blinc Group cannabis vape maker
Pete Sahani will succeed Arnaud Dumas de Rauly as CEO of The Blinc Group, a New York-City based…
News November 28Marijuana lab-testing analysis finds routine THC inflation, data manipulation
The THC potency of marijuana flower sold in legal stores in four states is routinely and systematically inflated,…
News November 28




















